Evidence map›Paper›PMID 30556012›Full record

ArticleACS omega2018

β-Glucosidase Discovery and Design for the Degradation of Oleuropein.

Kathryn G Guggenheim, Lauren M Crawford, Francesca Paradisi, Selina C Wang, Justin B Siegel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. β-Glucosidase Activity ofFoods (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kathryn G GuggenheimDepartment of Chemistry, Biochemistry & Molecular Medicine, and the Genome Center, Department of Food Science and Technology, and Olive Center, Robert Mondavi Institute for Wine and Food Science, University of California, Davis, One Shields Avenue, Davis, California 95616, United States.
Lauren M CrawfordDepartment of Chemistry, Biochemistry & Molecular Medicine, and the Genome Center, Department of Food Science and Technology, and Olive Center, Robert Mondavi Institute for Wine and Food Science, University of California, Davis, One Shields Avenue, Davis, California 95616, United States.
Francesca ParadisiDepartment of Chemistry, Biochemistry & Molecular Medicine, and the Genome Center, Department of Food Science and Technology, and Olive Center, Robert Mondavi Institute for Wine and Food Science, University of California, Davis, One Shields Avenue, Davis, California 95616, United States.
Selina C WangDepartment of Chemistry, Biochemistry & Molecular Medicine, and the Genome Center, Department of Food Science and Technology, and Olive Center, Robert Mondavi Institute for Wine and Food Science, University of California, Davis, One Shields Avenue, Davis, California 95616, United States.
Justin B SiegelDepartment of Chemistry, Biochemistry & Molecular Medicine, and the Genome Center, Department of Food Science and Technology, and Olive Center, Robert Mondavi Institute for Wine and Food Science, University of California, Davis, One Shields Avenue, Davis, California 95616, United States.
University of California, Davis · USUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current lye processing for debittering California black table olives produces large amounts of caustic wastewater and destroys many of the beneficial phenolic compounds in the fruit. Herein, we propose using enzyme treatment in place of lye, potentially reducing the amount and causticity of wastewater produced. By specifically targeting the bitterness-causing compound, oleuropein, retention of other beneficial phenolics may be possible. A β-glucosidase from

Identifiers

PMID30556012
PMCPMC6288900
OpenAlexW2901112932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.